Get notified when RANI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Material Weakness (new) — Company disclosed a new material weakness in controls over complex transactions as of December 31, 2025, rendering disclosure controls ineffective.
  • Going Concern (unchanged) — Filing states that conditions raise substantial doubt about the company's ability to continue as a going concern. The same disclosure appeared in the baseline filing.
  • Auditor Change (new) — Marcum LLP's attest business was acquired by CBIZ CPAs P.C. effective November 1, 2024, resulting in auditor change mid-period.
NASDAQ: RANI Rani Therapeutics Holdings, Inc. 10-K

RANI: revenue $1.6M, net income -$29.7M. Rani secures Chugai deal, repays all debt—but discloses control weakness

Filed March 26, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~1 min read

Key Changes

  • high

    Initiated Phase 1 trial for RT-114 obesity drug (RaniPill HC platform) in December 2025, advancing first high-capacity device into human testing after preclinical validation.

    Business: Pipeline Development verify on EDGAR →
  • high

    Discontinued RT-102 (osteoporosis) and RT-110 (hypoparathyroidism) programs; cut headcount 34% (105 to 69 employees) as part of strategic refocusing on obesity and partnerships.

    Business: Strategic Prioritization verify on EDGAR →
  • high

    Identified material weakness in internal controls over complex transactions; disclosure controls now deemed ineffective, though no prior misstatements occurred. Remediation underway.

    Controls & Procedures verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

Partner

Trade RANI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify